Hahn J J - OmicsDI

Show results for

Unknown (2463)
Proteomics (61)
Transcriptomics (45)
Genomics (12)
Models (5)
Metabolomics (2)

Organisms

Homo sapiens (77)
Mus musculus (25)
Arabidopsis thaliana (5)
Rattus norvegicus (2)
Mammalia (1)
Rhagoletis pomonella (1)
Fundulus heteroclitus (1)
Xenopus laevis (1)
Andreprevotia sp. IGB-42 (1)
Caenorhabditis elegans (1)
Drosophila melanogaster (1)
Methylomonas sp. (1)
Polynucleobacter asymbioticus (1)
Polynucleobacter asymbioticus QLW-P1DMWA-1 (1)
Saccharomyces cerevisiae (1)
Sus scrofa domesticus (1)
Xanthomonas campestris pv. campestris str. B100 (1)
Zea mays (1)

Organisms

Homo sapiens (1)
Mus musculus (1)

Repository

pride (54)
biostudies-arrayexpress (48)
MassIVE (7)
BioModels (5)
EGA (5)
geo (2)
MetaboLights (2)
ENA (2)

Tissue

Cell culture (16)
Heart (5)
Brain (4)
Plant cell (3)
Skeletal muscle (3)
Blood cell (2)
Colon (2)
Epithelial cell (2)
Fibroblast (2)
Leaf (2)
Permanent cell line cell (2)
Pluripotent stem cell (2)
Skin (2)
Spleen (2)
Adipose tissue (1)
Adipose tissue of abdominal region (1)
Blood (1)
Blood platelet (1)
Cardiomyocyte cell line (1)
Cell suspension culture (1)
Dorsal striatum (1)
Embryo (1)
Etiolated plant tissue (1)
Fetal cardiomyocyte (1)
Liver (1)
Monocyte (1)
Myoblast (1)
Neutrophil (1)
Obsolete lymphoblast (1)
T cell (1)

Disease

Cardiovascular system disease (3)
Marinesco-Sjogren syndrome (2)
Hodgkin's lymphoma (1)
Mature T-cell and NK-cell lymphoma (1)
Brain cancer (1)
Chronic myeloid leukemia (1)
Colon cancer (1)
Diastolic heart failure (1)
Disease free (1)
Fabry disease (1)
Gray platelet syndrome (1)
Heart failure (1)
Leigh disease (1)
Metabolic dysfunction-associated steatotic liver disease (1)
Myopathy (1)
Myotonic dystrophy type 1 (1)
Prostate adenocarcinoma (1)
Prostate cancer (1)
Sialolithiasis (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (54)
Shotgun proteomics (38)
Bottom-up proteomics (8)
Gel-based experiment (3)
Mass spectrometry (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Data-dependent acquisition (2)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Data-independent acquisition (1)
SRM/MRM (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Illumina HiSeq 4000 (8)
NextSeq 2000 (3)
Applied Biosystems 1700 Chemiluminescent Microarray Analyzer (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 3000 (1)
LTQ (1)
LTQ Orbitrap Velos (1)
LTQ Orbitrap Velos ETD (1)
Orbitrap Exploris 480 (1)
Q Exactive (1)
TimsTOF Ultra (1)
Gas Chromatography MS - (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2023 (16)
2013 (12)
2020 (11)
2021 (10)
2024 (8)
2022 (8)
2026 (8)
2011 (7)
2017 (5)
2018 (5)
2019 (4)
2014 (4)
2015 (3)
2010 (3)
2006 (3)
2025 (3)
2012 (2)
2008 (2)
2004 (2)
2016 (2)

UNIPROT ID/AC

O60674 (2)
P20963 (2)
P24394 (2)
P29350 (2)
P29597 (2)
P35225 (2)
P42229 (2)
P51692 (2)
P78552 (2)
O14543 (1)
P06213 (1)
P35569 (1)
Q14627 (1)
Q5EG47 (1)

CHEBI ID

CHEBI:33699 (2)
CHEBI:131438 (1)
CHEBI:131988 (1)
CHEBI:132009 (1)
CHEBI:132032 (1)
CHEBI:132033 (1)
CHEBI:132034 (1)
CHEBI:132035 (1)
CHEBI:132038 (1)
CHEBI:132039 (1)
CHEBI:132490 (1)
CHEBI:132726 (1)
CHEBI:132731 (1)
CHEBI:132743 (1)
CHEBI:132744 (1)
CHEBI:132745 (1)
CHEBI:134114 (1)
CHEBI:134236 (1)
CHEBI:134237 (1)
CHEBI:134264 (1)
CHEBI:134265 (1)
CHEBI:134266 (1)
CHEBI:134273 (1)
CHEBI:134285 (1)
CHEBI:134435 (1)
CHEBI:134439 (1)
CHEBI:134446 (1)
CHEBI:134451 (1)
CHEBI:134459 (1)
CHEBI:134460 (1)

Metabolite Name

2-hydroxyglutaric acid (1)
2-ketoglutaric acid (1)
5-oxoproline (1)
CL 66:4 (1)
CL 68:4 (1)
DAG 24:0 (1)
DAG 26:0 (1)
DAG 28:0 (1)
DAG 28:1 (1)
DAG 30:0 (1)
DAG 30:1 (1)
DAG 30:2 (1)
DAG 31:1 (1)
DAG 32:0 (1)
DAG 32:1 (1)
DAG 32:2 (1)
DAG 32:3 (1)
DAG 33:1 (1)
DAG 33:2 (1)
DAG 34:0 (1)
DAG 34:1 (1)
DAG 34:2 (1)
DAG 34:3 (1)
DAG 35:1 (1)
DAG 35:2 (1)
DAG 36:0 (1)
DAG 36:1 (1)
DAG 36:2 (1)
DAG 36:3 (1)
DAG 37:1 (1)

First Public Date

2026 (1)
2015 (1)

Modelling Approach

Ordinary differential equation model (5)

Lab affiliation

Cedars-Sinai Medical Center (2)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104 Freiburg im Breisgau, Germany (2)
Biochemistry III, Department of Chemistry, Bielefeld University, Universitätsstr. 25, 33615 Bielefeld, Germany (1)
Carpita Lab; Department of Botany & Plant Pathology, Purdue University, USA (1)
Cebitec, Bielefeld University (1)
Cedars-Sinai Medical Center, Smidt Heart Institute (1)
Center for Diagnostics, Section Mass Spectrometry and Protemics, University Medical Center Hamburg-Eppednorf, Hamburg, Germany (1)
Dana-Farber Cancer Institute (1)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg im Breisgau, Germany (1)
Department of General Pediatrics, Neonatology and Pediatric Cardiology, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany (1)
Department of Pharmaceutical Sciences, School of Pharmacy,SUNY at Buffalo, Buffalo, New York 14221, United States (1)
Departments of Neuroscience and Psychiatry, The Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. (1)
Doping Control Center, Korea Institute of Science and Technology, Seoul, Republic of Korea (1)
Dr. Robert Ahrends Group leader lipidomics Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. Otto-Hahn-Straße 6b 44227 Dortmund, Germany (1)
Faculty of Chemistry, Biotechnology and Food Science, NMBU - Norwegian University of Life Sciences, N-1433 Ås, Norway (1)
Functional Proteomics Lab, University Clinics Jena, Thuringia, Germany (1)
Group Leader Protein Dynamics ISAS e.V. Otto-Hahn-Straße 6b 44227 Dortmund, Germany (1)
Group Leader Protein Dynamics Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. Otto-Hahn-Straße 6b 44227 Dortmund, Germany (1)
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (1)
ISAS Otto-Hahn-Str. 6b 44227 Dortmund Germany (1)
Institute of Animal Hygiene and Environmental Health, Centre for Infectious Medicine, Free University of Berlin, Robert-von-Ostertag-Str. 7-13, Berlin 14163, Germany. Jayaseelan.murugaiyan@fu-berlin.de, Department of Biotechnology, SRM University AP, Andhra Pradesh, Neerukonda, Mangalagiri, Andhra Pradesh 522 502, India. jayaseelan.m@srmap.edu.in (1)
Institute of Clinical Chemistry and Laboratory Medicine Section / Core Facility Mass Spectrometry and Proteomics (1)
Institute of Clinical Chemistry and Laboratory Medicine Section of Mass Spectrometric Proteomics, University Medical Center Hamburg Eppendorf, Hamburg, Germany. (1)
LSUHSC, Department of Biochemistry and Molecular Biology, Proteomics Core Facility, New Orleans, LA 70112 (1)
Lab for Metabolic Signaling, Department of Pediatrics, University of Groningen, University Medical Center Groningen (UMCG), 9713 AV Groningen, The Netherlands and School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, 26111 Oldenburg, Germany (1)
Leibnitz Institut für Analytische Wissenschaften-ISAS e.V., Dortmund, Germany (1)
Leibniz – Institut für Analytische Wissenschaften - ISAS - e.V., Otto-Hahn-Str.6b 44227 Dortmund, Germany phone: +49 231 1392-4143 fax: +49 231 1392-4850 http://www.isas.de (1)
Leibniz-Institut für Analytische Wissenschaften (ISAS), Dortmund, Germany (1)
Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V. Otto-Hahn-Str. 6b D-44227 Dortmund Germany Tel.: +49 (0) 231-1392-4143 Fax: +49 (0) 231-1392-4850 (1)
Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany. Tel: ++49-231-13924232; Fax: ++49-231-13924850 (1)

IsPrivate

False (5)

Modification

-17.026549 (2)
-18.010565 (2)
15.994915 (2)
42.010565 (2)
57.021464 (2)

Study type

Transcription profiling by array (22)
RNA-seq of coding RNA (10)
Comparative genomic hybridization by array (5)
ChIP-seq (5)
Unknown experiment type (2)
Hi-C (2)
4C (1)
ATAC-seq (1)

Release Date

2021 (272)
2023 (266)
2024 (254)
2022 (252)
2025 (247)
2020 (204)
2019 (169)
2018 (134)
2017 (113)
2016 (103)
2015 (96)
2014 (69)
2013 (58)
2010 (48)
2026 (42)
2012 (39)
2011 (38)
2009 (30)
2007 (17)
2008 (16)
2006 (11)
2004 (9)
2003 (9)
2005 (7)
2002 (2)
2001 (2)
1999 (2)
1998 (2)

Previous page
1 / 259
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 259
Next page

Sort by:

Relevance

Page size

Analysis of conformational exchange processes using methyl-TROSY-based Hahn echo measurements of quadruple-quantum relaxation.

Not available

S-EPMC10583286 | biostudies-literature

Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases.

Not available

S-EPMC6355082 | biostudies-literature

VRK1 is required in VRK2-methylated cancers of the nervous system

Collateral lethality occurs when loss of one paralog renders cancer cells dependent on the remaining paralog. Combining genome scale CRISPR/Cas9 screens coupled with RNA-sequencing in over 900 cancer cell lines, we found that cancers of nervous system lineage, including adult and pediatric gliomas a...

ORGANISM(S): Homo sapiens (Human)

2022-09-06 | PXD030599 | Pride

Phosphorylation

Multiplet-filtered and gradient-selected zero-quantum TROSY experiments for 13C1H3 methyl groups in proteins.

Not available

S-EPMC3280329 | biostudies-literature

Laboratory monitoring to reduce adverse drug-related events: a mixed methods study.

Not available

S-EPMC10398702 | biostudies-literature

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

Not available

S-EPMC5455807 | biostudies-literature

Modulation of ligand-field parameters by heme ruffling in cytochromes c revealed by EPR spectroscopy.

Not available

S-EPMC3258502 | biostudies-literature

Experimental and DFT studies: novel structural modifications greatly enhance the solvent sensitivity of live cell imaging dyes.

Not available

S-EPMC3742023 | biostudies-literature

STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-Δ^12,14-prostaglandin J₂ in Triple Negative Breast Cancer.

Not available

S-EPMC8511581 | biostudies-literature

A comprehensive protein profile analysis from clinical Sialoliths and its practical implications

We analyzed 29 Sialolith samples, employing classical Population Genetic principles (Hartl and Clark 1980 (1), Hahn 2018 (2)) and Systems Biology analysis (ed: by Rigoustsos and Stephanopoulos 2006 (3)) approaches to create specific algorithms designed for our research objectives. Using these method...

ORGANISM(S): Homo sapiens (Human)

2020-04-16 | PXD012422 | Pride

Protein fraction Disease Salivary duct Human sialoliths

Previous page
1 / 259
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 259
Next page

Sort by:

Relevance

Page size

2588 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Lab affiliation

Tags

IsPrivate

Modification

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets